380 Phase I study with weekly Paclitaxel (1h) infusion in heavily pretreated advanced breast cancer and ovarian cancer patients

1995 ◽  
Vol 31 ◽  
pp. S83
Author(s):  
U. Klaassen ◽  
H. Wilke ◽  
D. Strumberg ◽  
W. Eberhardt ◽  
M. Korn ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase I Study ◽  
Advanced Breast ◽  
Weekly Paclitaxel ◽  
Heavily Pretreated

scholarly journals Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (22) ◽  
pp. 36750-36760 ◽  
Author(s):  
Tongtong Zhang ◽  
Qing Li ◽  
Shanshan Chen ◽  
Yang Luo ◽  
Ying Fan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Advanced Breast

Capecitabine with Weekly Paclitaxel for Advanced Breast Cancer: A Phase I Dose-Finding Trial

Oncology ◽  
2004 ◽  
Vol 67 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Catrina Uhlmann ◽  
Pierluigi Ballabeni ◽  
Natalie Rijken ◽  
Peter Brauchli ◽  
Walter Mingrone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
Weekly Paclitaxel

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

2008 ◽  
Vol 44 (1) ◽  
pp. 84-91 ◽  
Author(s):  
Ahmad Awada ◽  
Fatima Cardoso ◽  
Christel Fontaine ◽  
Luc Dirix ◽  
Jacques De Grève ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Mtor Inhibitor ◽  
Advanced Breast

scholarly journals A Phase I Study of Lde225 in Combination with Docetaxel in Patients with Triple Negative (Tn) Advanced Breast Cancer (Abc): Geicam/2012-12

2014 ◽  
Vol 25 ◽  
pp. iv135 ◽  
Author(s):  
M. Martin ◽  
M. Ruiz-Borrego ◽  
J.M. Trigo ◽  
S. Antolin ◽  
J.A. Garcia Saenz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Advanced Breast
Sign in / Sign up

Export Citation Format

Share Document